VKTX - Financial Reports List - Viking Therapeutics, Inc. - IntrinsicAlpha

Viking Therapeutics, Inc. VKTX

Healthcare - Biotechnology - NASDAQ - US

$ 27.73

-4.95 %

$ 3.11 B

Market Cap

-23.49

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-66.80%	-62.79%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-43.94%	-57.89%
Annual Report	FY	10-K	2024-12-31	0.00%	-28.02%	-49.68%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-10.68%	-34.08%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-15.73%	-43.45%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-47.67%	-65.91%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-30.63%	-44.38%
Annual Report	FY	10-K	2023-12-31	0.00%	-27.48%	-43.31%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-46.80%	-68.34%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-10.29%	-34.65%

1